Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Am J Prev Med. 2019 Mar 21;56(5):736–741. doi: 10.1016/j.amepre.2018.12.006

Table 3.

Stratified multivariable adjusted HR (95% CI) of mortality associated with replacement of sitting time

All-Cause HR (95% CI) Cancer HR (95% CI) CVD HR (95% CI) Other HR (95% CI)
Men (n=22978) No. deaths=9469 No. deaths=2409 No. deaths=3282 No. deaths=3778
Replace with LPA 0.91 (0.89-0.93) 0.91 (0.88-0.98) 0.88 (0.83-0.91) 0.93 (0.88-0.97)
Replace with MVPA 0.74 (0.70-0.78) 0.88 (0.77-0.97) 0.73 (0.67-0.81) 0.66 (0.60-0.71)
Women (n=37976) No. deaths=10026 No. deaths=2580 No. deaths=3275 No. deaths=4171
Replace with LPA 0.89 (0.85-0.92) 0.92 (0.86-1.00) 0.89 (0.82-0.94) 0.84 (0.81-0.89)
Replace with MVPA 0.76 (0.71-0.81) 0.86 (0.78-0.96) 0.76 (0.68-0.82) 0.69 (0.63-0.76)
pinta: 0.13 LPA, 0.55 MVPA pint: 0.89 LPA, 0.86 MVPA pint: 0.76 LPA, 0.81 MVPA pint: 0.01 LPA, 0.34 MVPA
Age < 65 (n=15375) No. deaths=1742 No. deaths=793 No. deaths=396 No. deaths=553
Replace with LPA 0.94 (0.88-1.01) 0.94 (0.83-1.04) 0.97 (0.83-1.13) 0.91 (0.79-1.06)
Replace with MVPA 0.73 (0.66-0.86) 0.80 (0.66-0.97) 0.81 (0.62-1.06) 0.64 (0.50-0.80)
Age 65-<75 (n=33152) No. deaths=9825 No. deaths=2838 No. deaths=3033 No. deaths=3954
Replace with LPA 0.90 (0.88-0.94) 0.91 (0.86-0.97) 0.89 (0.83-0.94) 0.91 (0.88-0.97)
Replace with MVPA 0.74 (0.70-0.79) 0.86 (0.76-0.94) 0.74 (0.65-0.81) 0.69 (0.64-0.76)
Age ≥ 75 (n=12427) No. deaths=7928 No. deaths=1358 No. deaths=3128 No. deaths=3442
Replace with LPA 0.88 (0.85-0.92) 1.00 (0.83-1.11) 0.86 (0.81-0.92) 0.86 (0.80-0.91)
Replace with MVPA 0.74 (0.70-0.79) 0.97 (0.88-1.06) 0.76 (0.68-0.83) 0.65 (0.60-0.72)
pint: 0.04 LPA, 0.19 MVPA pint: 0.50 LPA, 0.15 MVPA pint: 0.11 LPA, 0.41 MVPA pint: 0.04 LPA, 0.26 MVPA
Normal weight BMI (n=24663) No. deaths=8173 No. deaths=1907 No. deaths=2678 No. deaths=3588
Replace with LPA 0.89 (0.86-0.94) 0.91 (0.86-1.01) 0.88 (0.82-0.94) 0.88 (0.86-0.94)
Replace with MVPA 0.70 (0.66-0.74) 0.89 (0.79-0.99) 0.68 (0.61-0.76) 0.62 (0.56-0.68)
Overweight BMI (n=24575) No. deaths=7645 No. deaths=2113 No. deaths=2562 No. deaths=2970
Replace with LPA 0.91 (0.88-0.94) 0.94 (0.88-0.98) 0.88 (0.83-0.94) 0.91 (0.86-0.97)
Replace with MVPA 0.78(0.74-0.86) 0.86 (0.76-0.97) 0.81 (0.72-0.89) 0.74 (0.68-0.83)
Obese BMI (n=11716) No. deaths=3677 No. deaths=969 No. deaths=1317 No. deaths=1391
Replace with LPA 0.89 (0.83-0.94) 0.91 (0.81-1.00) 0.86 (0.79-0.97) 0.89 (0.81-0.97)
Replace with MVPA 0.74 (0.67-0.81) 0.83 (0.70-0.99) 0.74 (0.64-0.86) 0.70 (0.60-0.80)
pint: 0.68 LPA, 0.05 MVPA pint: 0.98 LPA, 0.57 MVPA pint: 0.57 LPA, 0.23 MVPA pint: 0.83 LPA, 0.04 MVPA

Models adjust for age (continuous), sex, race (white, other), alcohol use (non-drinker, <1, 1, ≥2 drinks/day, unknown), smoking status (never, current, former), years since quitting among former smokers (<10, 10-19, ≥ 20 years), cigarette frequency and smoking duration among current smokers (<20 cigarettes/day for ≤35 years, <20 cigarettes/day for >35 years, 20+ cigarettes/day for ≤35 years, 20+ cigarettes/day for >35 years), aspirin use (non-user, <15, 15-29, 30+ pills/month, unknown), education (high school or some college, college graduate or higher, unknown), occupational status (employed, not employed/retired), ACS dietary guidelines adherence score (0-<3, 3-<6, ≥6, unknown),(17) comorbidity score (0, 1, ≥2 comorbidities, including high blood pressure, diabetes, and high cholesterol), and BMI (continuous, [kg/m2]). Only moderate and low active participants included (n=60,954).

a

p value for interaction by PA category, boldface indicates statistical significance (p<0.05).

HR = hazard ratio; CI = confidence interval; CVD = cardiovascular disease.